Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Shockwave Medical Inc

(NASDAQ: SWAV)
Add to Portfolio
+0.24 (+0.73%)
as of Sep 17, 2019

Last 33.09
Change +0.24 (+0.73%)
Open 32.78
Prev. Close 32.85
Today's Range
32.20
34.48
52wk Range
24.58
68.39
Volume 563,000
Avg Volume 678,590
Sector SIC-3841 Surgical & Medical Instruments & Apparatus

Perfomance Comparison

Name Today 3-Month 1-Year
SWAV +0.73% -33.61% +8.49%
DJIA +0.13% +1.14% +4.02%
S&P 500 +0.26% +1.00% +4.05%

Key Statistics

Annual EPS N/A
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 859,580
Weighted Alpha -30.10
Standard Deviation +0.18
Profit Margin N/A
Beta N/A

Growth Rates

YTD +8.49%

Opinion

Sell Hold Buy

Recent Headlines

Shockwave Medical to Participate in Upcoming Investor

GlobeNewswire via COMTEX - Wed Aug 21, 08:30AM EDT
Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced the company will be participating in (full story)
WFC: 48.76 (-0.22), SWAV: 33.09 (+0.24)

Shockwave Appoints Hajime Tada as General Counsel

GlobeNewswire via COMTEX - Mon Jun 10, 08:00AM EDT
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the Company has appointed Hajime(full story)
A: 76.40 (-0.75), SWAV: 33.09 (+0.24)

Growing Global Demand for Non-Invasive Cellulite

PR Newswire via COMTEX - Wed May 29, 08:50AM EDT
Cellulite affects 85% to 90% of all women worldwide and was first described nearly 100 years ago, and has been the bane of women (and men) ever since. But to find a 'cure' or effective 'solution' the cause must be understood. Firs(full story)
BSX: 42.32 (+0.38), SESN: 1.12 (-0.06), SWAV: 33.09 (+0.24), PFE: 36.50 (-0.33), SOLY: 13.94 (-0.24)

Ally Bridge Group Leads Pulmonx's $65 Million

PR Newswire via COMTEX - Thu May 09, 10:05PM EDT
Ally Bridge Group ("ABG"), a leading global life science investment group, announced today that it led an over-subscribed $65 million financing of Pulmonx Corporation, a global leader in diagnostic and therapeutic pulmonary device(full story)
VAPO: 9.91 (+0.50), SILK: 35.39 (+0.48), MHMNF: 54.5000 (unch), KIDS: 38.39 (unch), SWAV: 33.09 (+0.24), AXNX: 31.94 (+1.67)